EW

EW

USD

Edwards Lifesciences Corporation Common Stock

$84.150+1.100 (1.325%)

Цена в режиме реального времени

Healthcare
Медицинские приборы
Соединенные Штаты

График цен

Loading Chart...

Ключевые показатели

Рыночные показатели
Фундаментальные показатели компании
Статистические данные торговли

Рыночные показатели

Открытие

$83.050

Максимум

$84.830

Минимум

$82.890

Объем

2.64M

Фундаментальные показатели компании

Рыночная капитализация

49.4B

Отрасль

Медицинские приборы

Страна

United States

Статистические данные торговли

Средний объем

4.58M

Биржа

NYQ

Валюта

USD

52-недельный диапазон

Минимум $64.89Текущая $84.150Максимум $87.09

Связанные новости

Analyst Upgrades

Truist Securities Maintains Hold on Edwards Lifesciences, Raises Price Target to $90

Truist Securities analyst Richard Newitter maintains Edwards Lifesciences with a Hold and raises the price target from $87 to $90.

Просмотреть больше
Truist Securities Maintains Hold on Edwards Lifesciences, Raises Price Target to $90
Analyst Upgrades

Barclays Maintains Overweight on Edwards Lifesciences, Raises Price Target to $99

Barclays analyst Matt Miksic maintains Edwards Lifesciences with a Overweight and raises the price target from $95 to $99.

Просмотреть больше
Barclays Maintains Overweight on Edwards Lifesciences, Raises Price Target to $99
Analyst Upgrades

Citigroup Maintains Buy on Edwards Lifesciences, Raises Price Target to $96

Citigroup analyst Joanne Wuensch maintains Edwards Lifesciences with a Buy and raises the price target from $95 to $96.

Просмотреть больше
Citigroup Maintains Buy on Edwards Lifesciences, Raises Price Target to $96
Analyst Upgrades

JP Morgan Maintains Neutral on Edwards Lifesciences, Raises Price Target to $90

JP Morgan analyst Robbie Marcus maintains Edwards Lifesciences with a Neutral and raises the price target from $85 to $90.

Просмотреть больше
JP Morgan Maintains Neutral on Edwards Lifesciences, Raises Price Target to $90
Analyst Upgrades

Goldman Sachs Maintains Buy on Edwards Lifesciences, Raises Price Target to $104

Goldman Sachs analyst David Roman maintains Edwards Lifesciences with a Buy and raises the price target from $94 to $104.

Просмотреть больше
Goldman Sachs Maintains Buy on Edwards Lifesciences, Raises Price Target to $104
Analyst Upgrades

Piper Sandler Reiterates Overweight on Edwards Lifesciences, Raises Price Target to $95

Piper Sandler analyst Adam Maeder reiterates Edwards Lifesciences with a Overweight and raises the price target from $90 to $95.

Analyst Upgrades

RBC Capital Maintains Outperform on Edwards Lifesciences, Raises Price Target to $95

RBC Capital analyst Shagun Singh maintains Edwards Lifesciences with a Outperform and raises the price target from $89 to $95.

Оставаться в курсе

Установите ценовой сигнал, получите обновления анализа ИИ и новости рынка в режиме реального времени.